Fujian Provincial Hospital
Fuzhou, Fujian, 350001, China
Location status: Recruiting
NCT Number: NCT06021080
It is unclear whether different modes of continuous renal replacement therapy (CRRT) impact post-filter ionized calcium concentrations during regional citrate anticoagulation (RCA) when using calcium-containing replacement fluid.
This prospective, single-center, observational cohort study will screen all patients receiving CRRT for eligibility. General clinical information will be collected before commencing CRRT treatment. Patients will be randomly assigned to either the veno-venous hemofiltration (CVVH) or continuous veno-venous hemodialysis (CVVHD) group and switch to the alternative mode in the subsequent treatment session. Pre-filter and post-filter ionized calcium, systemic total and ionized calcium, and effluent total and ionized calcium will be measured 2 hours after the initiation of CRRT. Electrolyte levels, arterial blood gases, hourly citrate dose, and total citrate dose will be recorded every 6 hours until the end of CRRT. The primary outcome is the difference in ionized calcium concentrations at each site over time between the two modes.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Fuzhou, Fujian, 350001, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CVVH therapy
CVVHD therapy
Time frame: 2 hours after the initiation of CRRT
The post-filter ionized calcium concentration
Time frame: 2 hours after the initiation of CRRT
Serum ionized calcium concentration
Time frame: 2 hours after the initiation of CRRT
Serum total calcium concentration
Time frame: 2 hours after the initiation of CRRT
Effluent total calcium concentration
Time frame: 48 hours after the initiation of CRRT
Including hypercalcemia, hypocalcemia, metabolic acidosis, metabolic alkalosis, citrate accumulation, hypernatremia, and hyponatremia
Contact information is provided by the study sponsor or research team.
Han Chen, Ph.D., M.D.
CONTACT
Wan-Li Yan, M.D.
CONTACT
Fujian Provincial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04937868
Abdominal Injuries, Abdominal Injury
Los Angeles, California, United States
View Trial DetailsNCT04265599
Calcium Metabolism Disorders, Hypercalcemia
Copenhagen, Denmark
View Trial DetailsNCT06109714
Acute Kidney Injury, Female Urogenital Diseases
View Trial DetailsNCT07341269
Calculi, Female Urogenital Diseases
Istanbul, Turkey (Türkiye)
View Trial Details